Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Gastro Today
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Hepatitis
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Metabolic Care Today
Diabetes
Obesity
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Sleep
More
Career News
Future of Medicine
Health and Wellness
— HIV
Infectious Diseases
Lupus
Neurology
Oncology
Ophthalmology
— Demodex Blepharitis
Orthopedics
Pharmacology
Pulmonology
Rheumatology
Urology
Rebekah R. White, MD, FACS
Rebekah R. White, MD, FACS, of University of California, San Diego
Articles by Rebekah R. White, MD, FACS
Local Ablation in Pancreatic Cancer: Ongoing Trials and Investigative Directions
Rebekah R. White, MD, FACS
Pancreatic Cancer
|
July 10, 2025
Drs. White and Berman consider how the post hoc analysis of CROSSFIRE elucidates the benefit of ablative therapy with IO.
View More
Local Ablation in Pancreatic Cancer: IRE Versus SBRT
Rebekah R. White, MD, FACS
Pancreatic Cancer
|
July 10, 2025
Drs. White and Berman share insights gained from the CROSSFIRE trial comparing IRE with SBRT in advanced pancreatic cancer.
View More